Matthew Greenhawt
Corporate Officer/Principal chez Intrommune Therapeutics, Inc.
Postes actifs de Matthew Greenhawt
Sociétés | Poste | Début | Fin |
---|---|---|---|
Intrommune Therapeutics, Inc.
Intrommune Therapeutics, Inc. MiscellaneousMiscellaneous Intrommune Therapeutics, Inc. operates as a biopharmaceutical company. The firm develops oral mucosal immunotherapy(OMIT) platform for food allergies. The company was founded by Michael Nelson and William Reisacher in 2015 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Historique de carrière de Matthew Greenhawt
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Sectorielle
Miscellaneous | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Intrommune Therapeutics, Inc.
Intrommune Therapeutics, Inc. MiscellaneousMiscellaneous Intrommune Therapeutics, Inc. operates as a biopharmaceutical company. The firm develops oral mucosal immunotherapy(OMIT) platform for food allergies. The company was founded by Michael Nelson and William Reisacher in 2015 and is headquartered in New York, NY. | Miscellaneous |
- Bourse
- Insiders
- Matthew Greenhawt
- Expérience